Quarterly report pursuant to Section 13 or 15(d)

Description of Business

v2.3.0.15
Description of Business
9 Months Ended
Sep. 30, 2011
Description of Business [Abstract]  
Description of Business
1.  Description of Business

XOMA Ltd. (“XOMA” or the “Company”), a Bermuda company, is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat autoimmune, cardio-metabolic, infectious, inflammatory and oncological diseases. The Company's products are presently in various stages of development and are subject to regulatory approval before they can be commercially launched.